Swiss National Bank’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Swiss National Bank’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-58,000	Closed	-$1.96M	–	2638
2021 Q2	$1.96M	Sell	58,000 -1,800	-3%	-$45.9K	﹤0.01%	2112
2021 Q1	$1.4M	Buy	59,800 +800	+1%	+$24.2K	﹤0.01%	2208
2020 Q4	$1.7M	Hold	59,000	–	–	﹤0.01%	2000
2020 Q3	$1.2M	Buy	59,000 +900	+2%	+$22K	﹤0.01%	1994
2020 Q2	$1.75M	Buy	+58,100	New	+$2.09M	﹤0.01%	1791

Swiss National Bank's CNST Position: Q3 2021 in Review

Swiss National Bank sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 58,000 shares — an estimated $1.96M sold.

Swiss National Bank first reported a position in CNST in Q2 2020 and held it in 5 quarters. The position peaked at $1.96M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Swiss National Bank reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Swiss National Bank sold 58,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.96M.
Swiss National Bank first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 5 quarters.
Swiss National Bank's Constellation Pharmaceuticals, Inc. position peaked at $1.96M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Swiss National Bank's 13F filing for Q3 2021, filed 8 Nov 2021.